Assessment and management of abdominal obesity in patients with type 2 diabetes
CPD Previous     Next

Assessment and management of abdominal obesity in patients with type 2 diabetes

Peta Fenn Independent diabetes and lifestyle consultant nurse, Postgraduate Peninsula Health Institute, Peninsula Medical School, Plymouth

Cardiometabolic risk factors increase the likelihood of an individual developing metabolic and cardiovascular disease. Individuals with abdominal obesity are at greatest cardiometabolic risk of developing type 2 diabetes. Nurses are increasingly considering how to run health screening clinics for patients at risk of developing type 2 diabetes and coronary heart disease as well as for those who have already developed these conditions. This article examines the importance of considering abdominal obesity as a therapeutic target and the role of nurses in its assessment and management. In particular, the article focuses on abdominal obesity as a risk factor that nurses can assess easily and that is amenable to intervention.

Nursing Standard. 21, 25,37-44. doi: 10.7748/ns2007.02.21.25.37.c4525

Correspondence

enquiries@petafenn.com

Peer review

This article has been subject to double blind peer review